ARTICLE | Clinical News
CCD 1042 neuroactive steroid active at GABA receptors: Began Phase I trial in 24 healthy volunteers
October 11, 1993 7:00 AM UTC
CoCensys Inc. (COCN) Product: CCD 1042 neuroactive steroid active at GABA receptors Indication: Anticonvulsant in petit mal epilepsy and infantile spasm Status: Began Phase I trial in 24 healthy volu...